Click the link below to view the Sjögren's Foundation letter to the U.S. Food & Drug Administration regarding the abrupt shortage of hydroxychloroquine (Plaquenil).
During this critical time, the Foundation absolutely recognizes the urgent and profound global need to find an effective treatment for COVID-19. However, we need to ensure there is awareness and consideration for Sjögren's patients, and other autoimmune disease patients, who currently depend on this life-saving medication.
If you have experienced a shortage or refusal to refill of hydroxychloroquine (Plaquenil), please email DRUGSHORTAGES [at] fda [dot] hhs [dot] gov (DRUGSHORTAGES[at]fda[dot]hhs[dot]gov). Let your voice be heard that an increase supply is needed.